March 16, 2020 / 10:18 AM / 16 days ago

BRIEF-Reckitt Says Not Aware Of Evidence Ibuprofen Impacts Covid-19 Patients

March 16 (Reuters) - Reckitt Benckiser Group PLC:

* RECKITT -AWARE OF SOCIAL MEDIA IN FRANCE CONCERNS ON USE OF STEROIDS & NON-STEROIDAL ANTI-INFLAMMATORY PRODUCTS FOR ALLEVIATION OF COVID-19 SYMPTOMS

* RECKITT - NOT AWARE OF ANY EVIDENCE THAT IBUPROFEN ADVERSELY IMPACTS OUTCOME IN PATIENTS SUFFERING FROM COVID-19 INFECTION

* RECKITT - NEITHER RECEIVED NEW SAFETY INFORMATION NOR BEEN INVOLVED IN EVALUATION OF ANY ADVERSE EVENTS REGARDING USE OF IBUPROFEN IN COVID-19 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below